NCT Number: NCT02792075
Prognosis of Coronary Stenosis Based on Intracoronary Imaging; A Multicenter, Prospective Observational Study
The purpose of this study is to evaluate the prognosis of coronary stenosis based on intracoronary Imaging.
Interested in participating?
Request InfoKey information
Conditions
Age range
19 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Asan Medical Center, Seoul, Songpa-gu, South Korea
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients with intracoronary imaging
- Written consent
Exclusion criteria
- Severe calcification and/or severe tortuosity
- Lesion with previous bypass graft surgery (CABG)
- Left ventricular ejection fraction less than 30 %
- Coronary spasm
- Life expectancy less than 2 years
- Pregnancy or breast-feeding
Treatment and study plan
Primary outcomes
-
Target Vessel Failure
Time frame: 2 years
defined as composite event of cardiac death, non-fatal myocardiac infarction, target vessel revascularization
Secondary outcomes
-
All-cause death
Time frame: 5 years
-
Cardiac death
Time frame: 5 years
-
Number of myocardial infarction events
Time frame: 5 years
Q wave myocardial infarction or non Q wave myocardial infarction
-
Composite event of death or myocardial infarction
Time frame: 5 years
-
Composite event of cardiac death or myocardial infarction
Time frame: 5 years
-
Target Vessel revascularization
Time frame: 5 years
-
Target Lesion revascularization
Time frame: 5 years
-
Number of stent thrombosis events
Time frame: 5 years
DEFINITE stent thrombosis : acute coronary syndrome and angiographic or pathologic evidence of stent thrombosis; PROBABLE stent thrombosis : unexplained death within 30 days or target-vessel infarction without angiographic information Academic Research Consortium (ARC) stent thrombosis is reported as a cumulative value at different time points and within the different separate time points. Time 0 is the time point after the guide catheter has been removed. Acute stent thrombosis: 0-24 hours after stent implantation; Subacute stent thrombosis: >24 hours to 30 days post; late stent thrombosis: >30 days to 1 year post; Very late stent thrombosis: >1 year post;
-
Number of stroke
Time frame: 5 years
-
Procedural success
Time frame: 7 days
Defined as mean lesion diameter stenosis less than 30% and without the occurrence of in-hospital myocardial infarction (MI), target vessel revascularization (TVR), or death
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Seung-Jung Park
Other
Collaborators
- CardioVascular Research Foundation, Korea
Registry information
Acronym: IRIS imaging
Important dates
- Study start
- 2016
- Primary completion
- 2026
- Study completion
- 2030
- First posted
- Jun 7, 2016
- Registry last updated
- Jan 2, 2026
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
QFR-Guided Virtual Stenting for Preprocedural Physiological Optimization of Percutaneous Coronary Intervention: A Randomized Controlled Trial
NCT07635407
Arterial Occlusive Diseases, Arteriosclerosis
Beijing, Beijing Municipality, China
View Trial DetailsIRIS-Coroflex NEO Cohort
NCT06177743
Arterial Occlusive Diseases, Arteriosclerosis
Seoul, Songpa-gu, South Korea
View Trial DetailsArtificial Intelligence-Driven Medipixel Fractional Flow Reserve Versus Invasive Fractional Flow Reserve-Guided PCI Trial (AIM-FFR Trial)
NCT07329699
Acute Coronary Syndrome, Arterial Occlusive Diseases
Seoul, Select State, South Korea
View Trial DetailsSingle vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)
NCT06535568
Acute Coronary Syndrome, Antineoplastic Agents
Milan, MI, Italy
View Trial Details